Skip to main content
OpenTrials
Completed

NCT Number: NCT07696780

Diabetes Management Among Women Using an AID System: a Mixed Method Study

Automated insulin delivery (AID) systems substantially improve diabetes management in people with type 1 diabetes but do not account for menstrual cycle related changes in insulin sensitivity. As a result, many menstruating individuals rely on manual adjustments, such as entering fake carbohydrates, modifying insulin settings, or changing basal rates, to maintain glycemic control. This study aims to systematically characterize these manual adjustment strategies, estimate how frequently they are used across the menstrual cycle, and explore their perceived burden, effectiveness, and implications for the development of future AID algorithms that better address menstrual cycle related insulin variability.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

DCB Research AG

Bern, Canton of Bern, 3010, Switzerland

About this study

Background Automated insulin delivery (AID) systems are expected to substantially improve diabetes management in people with type 1 diabetes but do not account for menstrual cycle related changes in insulin sensitivity, leading many menstruating individuals to rely on manual adjustments such as modifying insulin settings or entering "fake carbohydrates" to maintain glycemic control. This study will address the limited evidence in this area by systematically characterizing the range of manual adjustment strategies used across the menstrual cycle to inform the development of future AID systems.

Methods A mixed methods study design will be used, comprising an online survey followed by semi structured online focus groups with a subset of survey participants. The survey will capture self reported manual adjustment practices, while the focus groups will explore these strategies in greater depth through participant discussions to better understand the range, rationale, and variation of approaches used across the menstrual cycle.

Objectives The primary objective will be to identify and characterize manual adjustment strategies used by menstruating individuals with type 1 diabetes to compensate for menstrual cycle related changes in insulin requirements while using automated insulin delivery systems. Secondary objectives will include assessing the frequency, perceived burden and effectiveness of these strategies, their variation across the menstrual cycle, and identifying user needs to inform the development of future AID systems.

Outcomes Primary endpoints will be user reported manual adjustment strategies and perceptions of AID system use across the menstrual cycle. Secondary endpoints will include the frequency and perceived effectiveness of these strategies, user needs and preferences for AID systems, satisfaction with current system responsiveness, and the impact of menstrual cycle related adjustments on daily life.

Procedures Participants will be recruited through social media and partner networks and will complete an online REDCap survey that includes eligibility screening, informed consent, and collection of baseline characteristics, diabetes management, and menstrual cycle information. Eligible and interested participants will be invited to semi structured online focus groups (approximately five participants per group) to discuss manual adjustment strategies used during the menstrual cycle.

Statistical analysis No formal sample size calculation will be performed for the quantitative survey. Focus group data will be collected until thematic saturation is reached and will be analysed using thematic content analysis in Atlas.ti, involving transcription, coding, development of themes, and exploration of recurring patterns and relationships in manual adjustment strategies. Quantitative data will be analysed using R and Python.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years old
  • Good knowledge of English or German
  • Type 1 diabetes since >3 years
  • Regular menstrual cycle (24-35 days) since >2 years
  • Using one of the following AID systems: Tandem t-slim:X2 with Control-IQ; Medtronic 780G; DBLG1 (Kaleido, AkkuChek Insight); CAMAPS FX (Ypsopump, Dana); Omnipod 5; AAPS DIY; IAPS DIY; Loop DIY

Treatment and study plan

Primary outcomes

  1. Type of manual adjustment to AID settings to manage menstrual cycle related changes in insulin requirement

    Time frame: One full menstrual cycle (24 - 35 days)

    Semi-structured interviews will be analyzed using reflexive thematic analysis. Participant-reported strategies used to adjust AID system behavior in response to menstrual cycle-related changes in insulin requirements will be coded into themes (e.g., fictitious carbohydrate entries, temporary glucose targets, manual boluses, profile changes). The number of participants reporting each strategy will be summarized descriptively.

Secondary outcomes

  1. Frequency of manual adjustments across the menstrual cycle

    Time frame: One full menstrual cycle (24 - 35 days)

    Identify frequencies of manual adjustments applied by the participants

  2. Perceived burden related to manual adjustments (scale 1 - 5)

    Time frame: One full menstrual cycle (24 - 35 days)

    Perception of burden related to manual adjustments which are related to the menstrual cycle

  3. Self-reported assessment of effectiveness of manual adjustment strategies on glucose control

    Time frame: One full menstrual cycle (24 - 35 days)

    Participants' self reported perception of how well manual adjustment strategies help maintain glycemic control and support diabetes management during different phases of the menstrual cycle.

Sponsors and collaborators

Lead sponsor

DCB Research AG

Other

Registry information

Acronym: DESTINY

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jul 10, 2026
Registry last updated
Jul 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.